91 results
S-8
CGTX
Cognition Therapeutics Inc
26 Mar 24
Registration of securities for employees
4:53pm
for the purpose of registering an additional 643,309 shares of common stock, par value $0.001 per share (“Common Stock”), of Cognition Therapeutics, Inc … for the purpose of further updating such description; and
Our Current Reports on Form 8-K filed with the SEC on January 4, 2024; February 20, 2024
8-K
EX-1.1
CGTX
Cognition Therapeutics Inc
13 Mar 24
Entry into a Material Definitive Agreement
4:07pm
or directors of the Company pursuant to any stock or option plan duly adopted for such purpose by a majority of the non-employee members of the Board … of Directors or a majority of the members of a committee of non-employee directors established for such purpose for services rendered to the Company, (b
424B5
CGTX
Cognition Therapeutics Inc
13 Mar 24
Prospectus supplement for primary offering
4:04pm
for that purpose is required, other than in the United States. Persons outside the United States who come into possession of this prospectus supplement … by this prospectus supplement in any jurisdiction where action for that
S-22
purpose is required. The securities offered by this prospectus
424B5
2j27l3
11 Mar 24
Prospectus supplement for primary offering
4:06pm
8-K
EX-10.1
ydu56y8sb45j7i
20 Feb 24
Departure of Directors or Certain Officers
4:44pm
424B4
hyyq pmjhybwc0w75n
8 Jan 24
Prospectus supplement with pricing info
4:11pm
8-K
EX-10.1
mij58hz ug
23 Dec 22
Entry into a Material Definitive Agreement
4:24pm
S-3
EX-4.4
lypi1ed5qa xy
23 Dec 22
Shelf registration
4:16pm
S-3
idkbw
23 Dec 22
Shelf registration
4:16pm
S-3
EX-1.2
rptvm13khi4cp6
23 Dec 22
Shelf registration
4:16pm
8-K
EX-1.1
03nzvw19ba
14 Nov 22
Cognition Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
8:00am